RP105 ameliorates hypoxia̸reoxygenation injury in cardiac microvascular endothelial cells by suppressing TLR4̸MAPKs̸NF-κB signaling

Int J Mol Med. 2018 Jul;42(1):505-513. doi: 10.3892/ijmm.2018.3621. Epub 2018 Apr 16.

Abstract

The radioprotective 105 kDa protein (RP105) has been implicated in the pathological process of multiple cardiovascular diseases through its functional and physical interactions with Toll‑like receptor 4 (TLR4). However, the effects of RP105 on cardiac microvascular endothelial cells (CMECs) in response to hypoxia̸reoxygenation (H̸R) injury have not been extensively investigated. The aim of the present study was to elucidate the potential roles of RP105 in the protection of CMECs against H̸R injury, and investigate the underlying mechanisms. CMECs isolated from Sprague‑Dawley rats were transduced with adenoviral vectors encoding RP105 or green fluorescent protein (GFP). At 48 h post‑transfection, CMECs were subjected to hypoxia for 4 h and reoxygenation for 2 h (H̸R) to simulate the in vivo ischemia̸reperfusion model. The mRNA and protein levels of RP105 were detected by reverse transcription‑quantitative polymerase chain reaction and western blot analysis, respectively. The effects of RP105 on CMEC proliferation, migration and apoptosis were measured by GFP‑8, Transwell chamber and flow cytometry assays, respectively. The secretion of interleukin (IL)‑6 and tumor necrosis factor (TNF)‑α in the culture medium was measured by ELISA. Moreover, the expression level of TLR4, p38 mitogen‑activated protein kinase (MAPK), extracellular-signal-regulated kinase 1̸2, c-Jun N-terminal kinase, nuclear factor (NF)‑κB̸p65, IL‑6, TNF‑α and intercellular adhesion melecule‑1 was evaluated by western blot analysis. The results demonstrated that RP105 was minimally expressed in CMECs subjected to H̸R injury. Overexpression of RP105 via adenoviral vectors was able to significantly protect CMECs against H̸R injury, as evidenced by the promotion of cell proliferation and migration, as well as the amelioration of inflammation and apoptosis. These beneficial effects were at least partly mediated through inhibition of TLR4̸MAPKs̸NF‑κB signaling. Therefore, RP105 may be a promising candidate for prevention against CMECs‑associated H̸R injury.

MeSH terms

  • Adenoviridae / metabolism
  • Animals
  • Antigens, CD / metabolism*
  • Cell Hypoxia
  • Cell Movement
  • Cell Proliferation
  • Endothelial Cells / metabolism*
  • Endothelial Cells / pathology
  • Male
  • Microvessels / pathology
  • Mitogen-Activated Protein Kinases / metabolism*
  • Myocardium / pathology*
  • NF-kappa B / metabolism*
  • Oxygen / metabolism*
  • Rats, Sprague-Dawley
  • Toll-Like Receptor 4 / metabolism*
  • Transduction, Genetic

Substances

  • Antigens, CD
  • Cd180 protein, rat
  • NF-kappa B
  • Toll-Like Receptor 4
  • Mitogen-Activated Protein Kinases
  • Oxygen